R Squared LTD Sellas Life Sciences Group, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, R Squared LTD holds 2,197 shares of SLS stock, worth $2,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,197Holding current value
$2,218% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SLS
# of Institutions
39Shares Held
5.68MCall Options Held
1.67MPut Options Held
74.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.32 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX794KShares$801,7730.12% of portfolio
-
Geode Capital Management, LLC Boston, MA605KShares$611,2420.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$434,6710.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$311,5503.71% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $20.8M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...